Market Cap

Jounce Therapeutics, Inc. Market Capitalization:

$101.6 Million

USD as of May 1, 2023

business Jounce Therapeutics, Inc. Company Profile

Jounce Therapeutics, Inc. Main Stock Listing

NASDAQ: JNCE

Market Capitalization History of Jounce Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Jounce Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $60.0 M -84.63%
Jan. 1, 2022 $390.0 M -33.81%
Jan. 1, 2021 $589.2 M 79.65%
Jan. 1, 2020 $328.0 M 50.12%
Jan. 1, 2019 $218.5 M -82.67%
Jan. 1, 2018 $1.26 B 45.84%
Jan. 1, 2017 $864.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Sell the task first.
Automate what repeats.
Publish a paid offer in minutes. Learn what buyers actually pay for before building agents, workflows, or services nobody buys.
Get Started Free
For AI operators, consultants, & service builders

Jounce Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Jounce Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: JNCE

Stock: FSX: 21J

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.